Netherlands (NL)

A proposal to create an extension to the European baseline series (2018) Wilkinson M, Gallo R, Goossens A, Johansen JD, Rustemeyer T, Sanchez-Perez J, Schuttelaar ML, Uter W Journal article Human IFN-gamma immunity to mycobacteria is governed by both IL-12 and IL-23 (2018) Martinez-Barricarte R, Markle JG, Ma CS, Deenick EK, Ramirez-Alejo N, Mele F, Latorre D, et al. Journal article From design to the clinic: practical guidelines for translating cardiovascular nanomedicine (2018) Cicha I, Chauvierre C, Texier I, Cabella C, Metselaar JM, Szebeni J, Dezsi L, et al. Journal article WHO/ILO work-related burden of disease and injury: Protocol for systematic reviews of occupational exposure to dusts and/or fibres and of the effect of occupational exposure to dusts and/or fibres on pneumoconiosis (2018) Mandrioli D, Schlunssen V, Adam B, Cohen RA, Colosio C, Chen W, Fischer A, et al. Journal article Risankizumab in patients with moderate to severe Crohn's disease: an open-label extension study (2018) Feagan BG, Panes J, Ferrante M, Kaser A, D'Haens GR, Sandborn WJ, Louis E, et al. Journal article Pausing controls branching between productive and non-productive pathways during initial transcription in bacteria (2018) Dulin D, Bauer DLV, Malinen AM, Bakermans JJW, Kaller M, Morichaud Z, Petushkov I, et al. Journal article Thiopurines in Inflammatory Bowel Disease: New Findings and Perspectives (2018) De Boer NKH, Peyrin-Biroulet L, Jharap B, Sanderson JD, Meijer B, Atreya I, Barclay ML, et al. Journal article rs495139 in the TYMS-ENOSF1 Region and Risk of Ovarian Carcinoma of Mucinous Histology (2018) Kelemen LE, Earp M, Fridley BL, Chenevix-Trench G, Fasching P, Beckmann M, Ekici AB, et al. Journal article Histopathological Revision for Gastroenteropancreatic Neuroendocrine Neoplasms in Expert Centers: Does It Make the Difference? (2018) Merola E, Zandee W, De Mestier L, Klumpen HJ, Geboes KP, Poczkaj K, W DH, Munir A Conference contribution Effect of Seladelpar on Pruritus in Primary Biliary Cholangitis: 26-Week Analysis of an Ongoing International, randomized, Dose Ranging Phase 2 Study (2018) Kremer A, Bowlus CL, Neff GW, Aspinall R, Galambos MR, Goel A, Hirschfield G, et al. Conference contribution